General Manager, Asia-Pacific

Iterative Health is a healthcare technology and services company powering the acceleration of clinical research to transform patient outcomes.

We built a leading performance-driven network of 100+ sites across the US, Europe, India, and Australia, conducting research directly in the communities where care is delivered across gastrointestinal, hepatology, obesity, and cardiology. By combining deep clinical trial expertise with cutting-edge AI, we connect sponsors' scientific ambitions with high-performing research teams that expedite and expand access to novel therapeutics for patients in need. Today, Iterative Health is headquartered in Cambridge, Massachusetts, and New York City with 250+ employees world-wide.

We're launching operations in APAC and we’re looking for a General Manager to lead the strategy, buildout, and scaling of our operations. This is a founding seat with a mandate to shape and run a region from the ground up, launching operations in Singapore as a hub for the region, plus supporting and growing our early footprint in India and Australia. We envision launching a regional hub and spoke model with Singapore as the hub, supporting patient recruitment and clinical trial execution across neighboring countries (e.g., Indonesia, Malaysia, etc.)

You will operate at whatever altitude a given market requires. Where a country lead is already in place, you will set direction, resourcing, and cadence while they own execution; where no one is yet in seat, you will build the site network, sponsor relationships, and operate rhythm directly.

You'll have full P&L ownership of a region, a direct line to the Global COO, and real authority to design the org as you go rather than inherit one. This is a high accountability executive leadership role for someone who has built a market or business from scratch and knows how to operate with real autonomy.

Where You’ll Drive Impact

Regional Launch & P&L Ownership

• Own full P&L accountability for the APAC region as it's built out across all markets, including revenue growth, operating performance, and resource allocation.

• Own buildout of Singapore clinical trial infrastructure, overseeing execution alongside our partnered local hospital system

• Own buildout of regional hub and spoke model, including strategy, logistics, roll out timing, and execution

• Design and tailor our operating model for each country

• Build the region's operating cadence, consistent with our broader company operating model.

• Balance near-term market execution with the investments and capabilities required to build a durable, scalable regional business.

Establishing New Market Power

• Establish deep relationships with Private Investigators to drive engagement and and buy-in to embedding clinical research alongside clinical care

• Establish deep relationships with our global and local sponsor partners to drive buy-in to this new model and shape the required operating rhythm to make trials successful together

• Establish new markets from the ground up and build a repeatable playbook for market entry.

• Identify the gaps between where each market is today and where it needs to be at scale, directing the org structure, systems, and processes to close them.

Stakeholder & Sponsor Leadership

• Serve as the senior point of contact and escalation for sponsors across APAC.

• Represent APAC to the Global COO and executive leadership on performance and investment decisions.

• Work with Life Sciences and global leadership to align on sponsor priorities across the